Pacific Biosciences of California Inc.’s technology could rapidly increase the number of rare diseases—and their causes—identified by sequencing. Researchers at Children’s Mercy Research Institute in ...

The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a key player in understanding complex diseases. Following the landmark ...

Diagnosis sequencing is key to improving hospital ratings and rankings by industry groups like U.S. News & World Report, Leapfrog Group and Vizient. Manual processes for identifying high value cases, ...